FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Aug. 20, 2007--Pediatrix
Medical Group, Inc. (NYSE: PDX) has expanded its patient services
offering in the Seattle metropolitan area with the acquisition of a
physician group that concentrates on obstetrical and high-risk
maternal-fetal medicine ultrasounds.
The seven physicians joining Pediatrix are board-certified
radiologists who support obstetricians and maternal-fetal medicine
subspecialists in that community, and work closely with Pediatrix's
maternal-fetal medicine physician subspecialists based in Seattle.
The ultrasound radiology practice was formed in the mid 1970s,
when obstetrical ultrasounds were routinely performed by radiologists.
The Seattle ultrasound practice maintains a focus on delivering high
quality efficient diagnostic radiology services for patients referred
by obstetricians and maternal-fetal medicine subspecialists.
"As our practice has grown, we've attracted radiologists who enjoy
working in a clinical setting that involves patient interaction," said
Jack H. Hirsch, M.D., a partner in the practice and Pediatrix's
medical director. "We've made sure that we're adding value to
referring physicians in our community by focusing on high-quality
diagnostic service and managing an efficient office, which includes
readily available appointments for patients, as well as comprehensive
diagnostic reporting to referring physicians managing pregnancies.
Working with Pediatrix and the physicians here in Seattle, I expect
that we'll be able to expand on important diagnostic initiatives in
Physicians who practice as part of Pediatrix staff neonatal
intensive care and pediatric intensive care units in Seattle.
Pediatrix's physician services also include a pediatric cardiology
practice in Tacoma, as well as maternal-fetal medicine practices with
offices throughout Seattle.
Pediatrix paid cash for the ultrasound radiology practice, which
is expected to positively contribute to earnings. No other terms of
the acquisition were disclosed.
Pediatrix Medical Group, Inc. is the nation's leading provider of
neonatal, maternal-fetal and pediatric physician subspecialty
services. Pediatrix physicians and advanced practitioners are
reshaping the delivery of care within the maternal-fetal, neonatal
intensive care and pediatric cardiology subspecialties, using
evidence-based tools, continuous quality initiatives and clinical
research to enhance patient outcomes and provide high-quality,
cost-effective care. Founded in 1979, its neonatal physicians provide
services at more than 240 neonatal intensive care units, and in many
markets they collaborate with affiliated maternal-fetal medicine,
pediatric cardiology physician subspecialists and pediatric
intensivists to provide a clinical care continuum. Combined, Pediatrix
and its affiliated professional corporations employ more than 950
physicians in 32 states and Puerto Rico. Pediatrix is also the
nation's largest provider of newborn hearing screens and newborn
metabolic screening. Additional information is available at
Certain statements and information in this press release may be
deemed to be "forward-looking statements" within the meaning of the
Federal Private Securities Litigation Reform Act of 1995.
Forward-looking statements may include, but are not limited to,
statements relating to our objectives, plans and strategies, and all
statements (other than statements of historical facts) that address
activities, events or developments that we intend, expect, project,
believe or anticipate will or may occur in the future are
forward-looking statements. These statements are often characterized
by terminology such as "believe," "hope," "may," "anticipate,"
"should," "intend," "plan," "will," "expect," "estimate," "project,"
"positioned," "strategy" and similar expressions, and are based on
assumptions and assessments made by Pediatrix's management in light of
their experience and their perception of historical trends, current
conditions, expected future developments and other factors they
believe to be appropriate. Any forward-looking statements in this
press release are made as of the date hereof, and Pediatrix undertakes
no duty to update or revise any such statements, whether as a result
of new information, future events or otherwise. Forward-looking
statements are not guarantees of future performance and are subject to
risks and uncertainties. Important factors that could cause actual
results, developments, and business decisions to differ materially
from forward-looking statements are described in Pediatrix's most
recent Annual Report on Form 10-K, including the section entitled
"Risk Factors". Additional factors include, but are not limited to:
the possible discovery of additional facts beyond those reviewed by
the Audit Committee; possible litigation related to the matters
investigated by the Pediatrix's Audit Committee or the restatements to
Pediatrix's financial statements and other historical disclosures; and
any regulatory actions of the SEC or the U.S. Attorney related to such
CONTACT: Pediatrix Medical Group, Inc.
Bob Kneeley, 954-384-0175, ext. 5300
Director, Investor Relations
SOURCE: Pediatrix Medical Group, Inc.